Pure Global

Effect of the Food Supplement TOTUM-070 on Lipid Metabolism - Trial NCT06243484

Access comprehensive clinical trial information for NCT06243484 through Pure Global AI's free database. This phase not specified trial is sponsored by Valbiotis and is currently Recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 180 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06243484
Recruiting
dietary supplement
Trial Details
ClinicalTrials.gov • NCT06243484
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of the Food Supplement TOTUM-070 on Lipid Metabolism
Clinical Study to Investigate the Effect of the Food Supplement TOTUM-070 on Lipid Metabolism in Moderately Hypercholesterolemic Subjects After 3 Months of Supplementation

Study Focus

Hypercholesterolemia

TOTUM-070

Interventional

dietary supplement

Sponsor & Location

Valbiotis

Esslingen, Germany

Timeline & Enrollment

N/A

Oct 04, 2023

Apr 30, 2025

180 participants

Primary Outcome

Evolution of fasting blood LDL cholesterol level

Summary

This clinical trial is to confirm the effects of TOTUM-070, a mix of 5 plants extracts,
 consumed at the daily regimen of two times per day, on fasting blood LDL cholesterol
 concentrations in moderately hypercholesterolemic subjects after 12 weeks of consumption
 (V3).

ICD-10 Classifications

Pure hypercholesterolaemia
Lipoprotein deficiency
Hyperglycaemia, unspecified
Disorders of lipoprotein metabolism and other lipidaemias
Other disorders of lipoprotein metabolism

Data Source

ClinicalTrials.gov

NCT06243484

Non-Device Trial